Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Malignant schwannoma following treatment for Hodgkin's disease.

Fisher PM., Dodwell DJ., Bridges LR., Cartwright SC., Stone J.

Two cases of malignant schwannoma are reported 13 and 15 years following combined modality treatment for Hodgkin's disease. Both patients survived for only 15 months. The aetiology of this rare condition is discussed.

More information Original publication

DOI

10.1016/s0936-6555(94)80063-4

Type

Journal article

Publication Date

1994-01-01T00:00:00+00:00

Volume

6

Pages

204 - 205

Total pages

1

Keywords

Adolescent, Antineoplastic Combined Chemotherapy Protocols, Child, Combined Modality Therapy, Female, Hodgkin Disease, Humans, Male, Mechlorethamine, Neoplasm Recurrence, Local, Neoplasms, Second Primary, Neurilemmoma, Prednisone, Procarbazine, Spinal Cord Neoplasms, Vincristine